Investigational Site Number : 0560008

Brussels 1200

2 studies enrolling now · 3 studies all time

What they study most

Fabry Disease, Multiple Sclerosis

Studies at this site

• Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis — Recruiting now
• Fabry Disease Registry & Pregnancy Sub-registry — Recruiting now
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling